Soonsolid, a leading technology company dentistry focused on 3D printing, has closed hundreds of millions of yuan in Series C Round Series C funding, led by China Life Private Equity investment Company, and
Sinopharm Capital, Beijing Kunlun Tech and a few other investors also participated in the round.
Soonsolid, founded in 2013, is a technology company specialized in print system and material innovation. By collaboration with worldwide prestigious universities and research organizations such as Additive Manufacturing Lab in University of Southern California(USC), Soonsolid mastered several advanced 3D printing technologies in DLP, SLA, ceramic printing, SIS metal printing, and 3D architecture printing.
Soonrsolid is pushing the boundary of additive manufacturing by offering a revolutionary solution of cutting edge material, innovated machine and intelligent software.
The system of Soonrsolid connects the cloud platform Dashboard2.0, design platform design service, Internet (SprintRay® official website), equipment (dental 3D printer, Pro Cure, ProWash / Dry) in series to form a digital dental Internet of Things, which enables users, The effective connection of things.
China Life Equity Investment Company Limited, a wholly-owned subsidiary of China Life Investment Holding Company Limited, was founded in June, 2016 in Shanghai Free Trade Zone. As a specialized private equity investment platform under China Life, it is the first investment institution that obtained the qualification of private fund manager on insurance funds after the relevant policies promulgated by CIRC, and it has successfully initiated the establishment of China Life Healthcare Fund, currently the largest flagship healthcare equity fund in China, with a total size of RMB 50 billion and the initial committed fund of RMB 12 billion.